Young Diane C. has filed 6 insider transactions across 1 company since June 2023.
Most recent transaction: a grant/award of 72000 shares of Celldex Therapeutics, Inc. ($CLDX) on June 05, 2025.
Activity breakdown: 0 open-market purchases and 1 sale.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| June 5, 2025 | Celldex Therapeutics, Inc. | $CLDX | Young Diane C. | SVP, CHIEF MEDICAL OFFICER | A | Incentive Stock Option (right to buy) | 72000 | $0.00 | 72,000.0000 | 66,383 | 9999.99% | 100.00% |
| June 13, 2024 | Celldex Therapeutics, Inc. | $CLDX | Young Diane C. | SVP, CHIEF MEDICAL OFFICER | A | Incentive Stock Option (right to buy) | 72000 | $0.00 | 72,000.0000 | 58,871 | 9999.99% | 100.00% |
| June 11, 2024 | Celldex Therapeutics, Inc. | $CLDX | Young Diane C. | SVP, CHIEF MEDICAL OFFICER | M | Common Stock | 15000 | $2.71 | 17,115.0000 | 58,871 | 709.22% | 25.48% |
| June 11, 2024 | Celldex Therapeutics, Inc. | $CLDX | Young Diane C. | SVP, CHIEF MEDICAL OFFICER | M | Incentive Stock Option | 15000 | $0.00 | 0.0000 | 58,871 | 100.00% | 25.48% |
| June 7, 2024 | Celldex Therapeutics, Inc. | $CLDX | Young Diane C. | SVP, CHIEF MEDICAL OFFICER | S | Common Stock | 45000 | $35.26 | 2,115.0000 | 58,871 | 95.51% | 76.44% |
| June 15, 2023 | Celldex Therapeutics, Inc. | $CLDX | Young Diane C. | SVP, CHIEF MEDICAL OFFICER | A | Incentive Stock Option (right to buy) | 80000 | $0.00 | 80,000.0000 | 47,214 | 9999.99% | 100.00% |